Adding Lantus® to Oral Antidiabetic Drug Therapy Further Reduced Blood Sugar in Patients with Type 2 Diabetes
Sanofi-aventis announced today results of two studies presented at the European Association for the Study of Diabetes 46th Annual Meeting in Stockholm, Sweden.  The first pooled analysis using patient-level data from randomized clinical trials demonstrated that adding Lantus® to patients with type 2 diabetes, uncontrolled on oral antidiabetic drug therapy , was associated with a greater …
Read more on PR Newswire via Yahoo! Finance
How can I reduce my child’s allergy risk?
Allergic disorders are among the most common chronic childhood diseases. According to the American Academy of Pediatrics, asthma affects nearly 5 million American children, while allergies like hay fever, food allergies and eczema, affect about 50 million.
Read more on The Tampa Tribune
Sanofi-aventis: Adding Lantus(R) to Oral Antidiabetic Drug Therapy Further Reduced Blood Sugar in Patients With Type 2 …
Sanofi-aventis announced today results of two studies presented at the European Association for the Study of Diabetes 46th Annual Meeting in Stockholm, Sweden. The first pooled analysis using patient-level data from randomized clinical trials demonstrated that adding Lantus (insulin glargine injection) to patients with type 2 diabetes, uncontrolled on oral antidiabetic drug therapy , was …
Read more on CNW Group via Yahoo! Finance
IBS Treatment Center in Seattle Moves to New Building
After 5 years in the First HIll area of downtown Seattle, the IBS Treatment Center is moving to a newly constructed building in the north Seattle medical district. Patients will benefit from free garage parking, street level entry, easier traffic, and a new clinic facility.
Read more on PRWeb via Yahoo! News